Clinical trials
Pancreatic Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 4 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 4 |
| University of Washington, the Collaborative Health Studies Coordinating Center | 2 |
| Agensys, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Boston Scientific Corporation | 1 |
| Celgene | 1 |
| Mandip Rai | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Rezolute | 1 |
| Sumitomo Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Diseases | 17 |
| Digestive System Diseases | 7 |
| Cystic Fibrosis | 6 |
| Genetic Diseases, Inborn | 6 |
| Lung Diseases | 6 |
| Pancreatic Neoplasms | 6 |
| Pathologic Processes | 5 |
| Respiratory Tract Diseases | 5 |
| Infant, Newborn, Diseases | 4 |
| Carcinoma, Pancreatic Ductal | 3 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.